BioCentury
ARTICLE | Clinical News

Simtuzumab: Phase II discontinued

February 1, 2016 8:00 AM UTC

A DMC recommended terminating an international Phase II trial of simtuzumab to treat IPF due to lack of efficacy. The DMC recommended continuing Phase II trials of simtuzumab to treat non-alcoholic st...